Reevaluating the safety of chamomile poultices in ophthalmic care

IntroductionGerman chamomile [Matricaria recutita L. (Asteraceae)] tea poultices are a common folk remedy in Central and Eastern Europe for treating eye inflammations such as blepharitis and conjunctivitis. This practice often precedes medical consultation and professional advice. Surprisingly, some...

Full description

Saved in:
Bibliographic Details
Main Authors: Tibor Rák, Adrienne Csutak
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1580586/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849312037927124992
author Tibor Rák
Tibor Rák
Adrienne Csutak
author_facet Tibor Rák
Tibor Rák
Adrienne Csutak
author_sort Tibor Rák
collection DOAJ
description IntroductionGerman chamomile [Matricaria recutita L. (Asteraceae)] tea poultices are a common folk remedy in Central and Eastern Europe for treating eye inflammations such as blepharitis and conjunctivitis. This practice often precedes medical consultation and professional advice. Surprisingly, some healthcare professionals, including pharmacists, naturopaths, general practitioners, and pediatricians, recommend it as a primary treatment, particularly among the elderly. However, the ophthalmic use of chamomile lacks scientific validation, and the European Medicines Agency (EMA) and ophthalmic guidelines warn of potential allergic reactions, including life-threatening anaphylaxis.MethodsThis review examines the origins and descriptions of herbal poultices, with a focus on chamomile, by analyzing data from Hungarian and international medical literature. The study highlights the unsanitary production and storage conditions, also the external application of chamomile teas, which increase the risk of infection and contamination.ResultsThe findings indicate that chamomile tea poultices pose significant health risks due to potential allergic reactions and microbiological contamination. The study underscores the lack of scientific evidence supporting the ophthalmic use of chamomile and the dangers associated with its application.DiscussionThe implications of these findings are critical for healthcare professionals and guideline developers. The study calls for discontinuing chamomile-based ophthalmic therapies and emphasizes the need for evidence-based practices. Future research should focus on validating the safety and efficacy of herbal remedies and developing guidelines to protect public health.
format Article
id doaj-art-c42bed8e1af54123a50fdbf3e2456a21
institution Kabale University
issn 1663-9812
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-c42bed8e1af54123a50fdbf3e2456a212025-08-20T03:53:12ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-05-011610.3389/fphar.2025.15805861580586Reevaluating the safety of chamomile poultices in ophthalmic careTibor Rák0Tibor Rák1Adrienne Csutak2Department of Pharmacognosy, Faculty of Pharmacy, University of Pécs, Pécs, HungaryDepartment of Ophthalmology, Medical School - Clinical Centre, University of Pécs, Pécs, HungaryDepartment of Ophthalmology, Medical School - Clinical Centre, University of Pécs, Pécs, HungaryIntroductionGerman chamomile [Matricaria recutita L. (Asteraceae)] tea poultices are a common folk remedy in Central and Eastern Europe for treating eye inflammations such as blepharitis and conjunctivitis. This practice often precedes medical consultation and professional advice. Surprisingly, some healthcare professionals, including pharmacists, naturopaths, general practitioners, and pediatricians, recommend it as a primary treatment, particularly among the elderly. However, the ophthalmic use of chamomile lacks scientific validation, and the European Medicines Agency (EMA) and ophthalmic guidelines warn of potential allergic reactions, including life-threatening anaphylaxis.MethodsThis review examines the origins and descriptions of herbal poultices, with a focus on chamomile, by analyzing data from Hungarian and international medical literature. The study highlights the unsanitary production and storage conditions, also the external application of chamomile teas, which increase the risk of infection and contamination.ResultsThe findings indicate that chamomile tea poultices pose significant health risks due to potential allergic reactions and microbiological contamination. The study underscores the lack of scientific evidence supporting the ophthalmic use of chamomile and the dangers associated with its application.DiscussionThe implications of these findings are critical for healthcare professionals and guideline developers. The study calls for discontinuing chamomile-based ophthalmic therapies and emphasizes the need for evidence-based practices. Future research should focus on validating the safety and efficacy of herbal remedies and developing guidelines to protect public health.https://www.frontiersin.org/articles/10.3389/fphar.2025.1580586/fullchamomileMatricaria recutitaocular poulticeconjunctivitishypersensitivityherbal tea
spellingShingle Tibor Rák
Tibor Rák
Adrienne Csutak
Reevaluating the safety of chamomile poultices in ophthalmic care
Frontiers in Pharmacology
chamomile
Matricaria recutita
ocular poultice
conjunctivitis
hypersensitivity
herbal tea
title Reevaluating the safety of chamomile poultices in ophthalmic care
title_full Reevaluating the safety of chamomile poultices in ophthalmic care
title_fullStr Reevaluating the safety of chamomile poultices in ophthalmic care
title_full_unstemmed Reevaluating the safety of chamomile poultices in ophthalmic care
title_short Reevaluating the safety of chamomile poultices in ophthalmic care
title_sort reevaluating the safety of chamomile poultices in ophthalmic care
topic chamomile
Matricaria recutita
ocular poultice
conjunctivitis
hypersensitivity
herbal tea
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1580586/full
work_keys_str_mv AT tiborrak reevaluatingthesafetyofchamomilepoulticesinophthalmiccare
AT tiborrak reevaluatingthesafetyofchamomilepoulticesinophthalmiccare
AT adriennecsutak reevaluatingthesafetyofchamomilepoulticesinophthalmiccare